Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literature.
Impact of appropriate pharmaceutical therapy for chronic conditions on direct medical costs and workplace productivity: a review of the literature.
复制标题
DOI：
10.1089/109350704322919005
复制
发表时间：
2004-01-01
影响因子：
--
通讯作者：
Cobb, Nicole
中科院分区：
文献类型：
--
作者：
Goldfarb, Neil;Weston, Christine;Cobb, Nicole
本文介绍了文献综述的结果，调查适当的药物治疗在治疗四种流行的慢性疾病-哮喘，糖尿病，心力衰竭和偏头痛的经济影响。该综述的目的是确定高质量的研究，研究适当的药物治疗对整体医疗支出（直接成本）和工作场所生产力（间接成本）的影响程度。进行审查的工作假设是，选定慢性病的药品费用被其他领域直接和间接费用的节省所抵消。文献提供的证据表明，适当的药物治疗可以改善慢性病患者的健康状况和生活质量，同时降低与急诊室，住院和其他医疗服务相关的费用。越来越多的证据也表明，那些慢性病得到药物有效控制的工人生产力更高。对于雇主来说，证据转化为潜在的直接和间接成本节约。研究结果还证实了药物管理作为疾病管理基石的重要性。
This paper presents the findings of a literature review investigating the economic impact of appropriate pharmaceutical therapy in treating four prevalent chronic conditions - asthma, diabetes, heart failure, and migraine. The goal of the review was to identify high-quality studies examining the extent to which appropriate pharmaceutical therapy impacts overall medical expenditure (direct costs) and workplace productivity (indirect costs). The working hypothesis in conducting the review was that the costs of pharmaceuticals for the selected chronic conditions are offset by savings in direct and indirect costs in other areas. The literature provides evidence that appropriate drug therapy improves the health status and quality of life of individuals with chronic illnesses while reducing costs associated with utilization of emergency room, inpatient, and other medical services. A growing body of evidence also suggests that workers whose chronic conditions are effectively controlled with medications are more productive. For employers, the evidence translates into potential direct and indirect cost savings. The findings also confirm the importance of pharmaceutical management as a cornerstone of disease management.